Novavax Reports Fourth Quarter and Year-End 2014 Financial Results

Go back to Novavax Reports Fourth Quarter and Year-End 2014 Financial Results

Novavax (NVAX) Misses Q4 EPS by 5c

February 26, 2015 4:20 PM EST

Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Novavax (NVAX) click here.

... More